Reconnecting Practicing Hygienists with the Nation's Leading Educators and Researchers.

New COVID-19 Vaccine to Seek Emergency Use Authorization from FDA

Sanofi and GSK are expected to request Emergency Use Authorization from the United States Food and Drug Administration (FDA) for its two-dose COVID-19 vaccine that uses traditional immunization technology rather than the new mRNA approach implemented by the Pfizer and Moderna COVID-19 shots. The new vaccine regimen demonstrated 100% efficacy against severe COVID-19 illness and hospitalization and 75% effectiveness against moderate to severe disease. This option may appeal to individuals who have declined vaccination due to unease regarding the mRNA technology. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy